- Home
- FEMY
FEMY
Femasys Inc.
as 11-20-2024 4:00pm EST
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
| Founded: | 2004 | Country: | United States |
| Employees: | 34 | City: | N/A |
| Market Cap: | 22.4M | IPO Year: | 2021 |
| Target Price: | $10.00 | AVG Volume (30 days): | 263.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.73 - $2.40 | Next Earning Date: | 11-12-2024 |
| Revenue: | $1,260,643 | Revenue Growth: | 15.33% |
| Revenue Growth (this year): | 135.27% | Revenue Growth (next year): | 310.75% |
Latest Femasys Inc. News
FEMY Breaking Stock News: Dive into FEMY Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Femasys Third Quarter 2024 Earnings: Misses Expectations
Zacks
9 days ago
Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
9 days ago
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
GlobeNewswire
14 days ago
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
MT Newswires
20 days ago
Femasys Says It Received US Patent for Female Birth Control Device FemBloc
GlobeNewswire
20 days ago
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
GlobeNewswire
22 days ago
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
GlobeNewswire
a month ago
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
Compare FEMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FEMY Femasys Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.